$170.85 -1.34 (%) Alexion Pharmaceuticals Inc - NASDAQ

Sep. 1, 2015 | 04:00 PM

Partner Headlines

  1. David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF

    GuruFocus | Aug. 19, 2015 | 18:27PM EST
  2. Baron Funds Comments on Alexion Pharmaceuticals Inc.

    GuruFocus | Aug. 19, 2015 | 12:16PM EST
  3. Yale University Is Bullish On ETFs & Alexion, Sold Twitter Last Quarter

    Benzinga | Aug. 13, 2015 | 16:24PM EST
  4. Dow Delays Death Cross With Big Monday Gain

    Benzinga | Aug. 11, 2015 | 07:43AM EST
  5. The Historical Correlation Between Biotech Stocks And Interest Rates

    Benzinga | Aug. 7, 2015 | 14:39PM EST
  6. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD | Aug. 5, 2015 | 14:58PM EST
  7. Big Cap Leaders Sail Past Earnings Season

    IBD | Aug. 3, 2015 | 18:48PM EST
  8. Amgen, Alexion Q2 Earnings Beat, But Guidance Differs

    IBD | Jul. 30, 2015 | 18:49PM EST
  9. Amgen, Alexion Profits Beat

    IBD | Jul. 30, 2015 | 18:47PM EST
  10. Alexion Facing Big Costs, Guidance Disappoints

    IBD | Jul. 30, 2015 | 12:48PM EST
  11. Stocks With Most Potential Have Strong Profit Outlook

    IBD | Jul. 28, 2015 | 18:46PM EST
  12. Biotech NantKwest Stock Surges On 1st Day Of Trading

    IBD | Jul. 28, 2015 | 12:08PM EST
  13. JP Morgan Moves Alexion Pharma To Overweight, Says Strensiq And Kanuma Are $1.7B Opportunity

    Benzinga | Jul. 27, 2015 | 08:18AM EST
  14. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD | Jul. 24, 2015 | 18:33PM EST
  15. Wall Street Mixed On Biogen Before Earnings

    Benzinga | Jul. 23, 2015 | 17:39PM EST
  16. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD | Jul. 13, 2015 | 18:43PM EST
  17. Allergan, Celgene Break Out As Other Medicals Base

    IBD | Jul. 13, 2015 | 18:43PM EST
  18. Big Cap 20: Does Edwards Lifesciences Have More Left?

    IBD | Jul. 6, 2015 | 18:53PM EST
  19. US Stock Futures Drop Ahead Of Economic Data

    Benzinga | Jul. 6, 2015 | 07:16AM EST
  20. Strensiq Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia

    Benzinga | Jul. 6, 2015 | 06:03AM EST
  21. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 30, 2015 | 00:18AM EST
  22. Bernstein: Alexion Pharma An Outperform, Worth $267/Share

    Benzinga | Jun. 23, 2015 | 09:50AM EST
  23. Alnylam Reports Data on Potential Alexion Rival Drug

    IBD | Jun. 12, 2015 | 12:38PM EST
  24. Stock Futures Dip After PPI Data; Twitter, Synaptics Grab Early Gains

    IBD | Jun. 12, 2015 | 09:04AM EST
  25. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 13:52PM EST
  26. Oppenheimer Downgrades Dyax

    Benzinga | May. 11, 2015 | 14:56PM EST
  27. Alexion Acquiring Synageva For $8.4 Billion

    GuruFocus | May. 9, 2015 | 18:13PM EST
  28. Morgan Stanley: Market's Reaction To Linger For Alexion Pharmaceuticals

    Benzinga | May. 7, 2015 | 16:03PM EST
  29. Here's What Canaccord Learned After Spending A Day With Synageva's Management

    Benzinga | May. 7, 2015 | 15:30PM EST
  30. Benzinga's Volume Movers

    Benzinga | May. 7, 2015 | 12:20PM EST
  31. How Wedbush Sees The Alexion–Synageva Deal

    Benzinga | May. 7, 2015 | 09:42AM EST
  32. Alexion To Acquire Synageva

    IBD | May. 6, 2015 | 18:56PM EST
  33. Alexion's $8.4 Billion Synageva Buyout Spooks Street

    IBD | May. 6, 2015 | 18:20PM EST
  34. Benzinga's M&A Chatter for Wednesday May 6, 2015

    Benzinga | May. 6, 2015 | 18:17PM EST
  35. Stocks Fall On Yellen Comment; Tesla Firm Ahead Of Earnings

    IBD | May. 6, 2015 | 13:23PM EST
  36. Stocks Down At Midday; Apple Flirts With Sell Signal

    IBD | May. 6, 2015 | 12:01PM EST
  37. Alexion Buying Synageva For $230 A Share; Stock Slips

    IBD | May. 6, 2015 | 10:48AM EST
  38. Benzinga's Volume Movers

    Benzinga | May. 6, 2015 | 10:40AM EST
  39. Synageva Shares Soar 116% On Buyout Deal With Alexion Pharmaceuticals

    Benzinga | May. 6, 2015 | 10:30AM EST
  40. Stocks Fade From Higher Open; Synageva Surges On Buyout News

    IBD | May. 6, 2015 | 10:28AM EST
  41. Morning Market Losers

    Benzinga | May. 6, 2015 | 09:56AM EST
  42. Morning Market Gainers

    Benzinga | May. 6, 2015 | 09:45AM EST
  43. Benzinga's Top #PreMarket Losers

    Benzinga | May. 6, 2015 | 08:23AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 6, 2015 | 08:14AM EST
  45. Alexion Pharma Reports New Data from Phase 2 Clinical Trial of Soliris in Prevention of Acute AMR in Sensitized Decreased-Donor Kidney Transplant Recipients

    Benzinga | May. 5, 2015 | 16:48PM EST
  46. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  47. AbbVie Tops, Alexion Misses

    IBD | Apr. 23, 2015 | 18:42PM EST
  48. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  49. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  50. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!